Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 28, 2005; 11(16): 2462-2466
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2462
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2462
Table 1 Distribution of age and course of the illness.
Age and course | 2000s group n (%) | 1990s group n (%) | |
Age (yr) | <30 | 21 (17.2) | 19 (17.9) |
30- | 31 (25.4) | 33 (31.1) | |
40- | 39 (32.0) | 21 (19.8) | |
50- | 14 (11.5) | 21 (19.8) | |
60- | 17 (13.9) | 12 (11.3) | |
Total course of the illness (yr) | <1.0 | 61 (50.0)a | 33 (31.7) |
1.0- | 48 (39.3) | 40 (37.7) | |
5.0- | 6 (4.9)a | 18 (17.0) | |
10.0- | 7 (5.7)a | 15 (17.0) | |
Course of present | |||
flare-up (yr) | <0.5 | 85 (69.7) | 71 (67.0) |
0.5- | 20 (16.4) | 17 (16.0) | |
1.0- | 17 (13.9) | 18 (17.0) |
- Citation: Chen QK, Yuan SZ, Wen ZF, Zhong YQ, Li CJ, Wu HS, Mai CR, Xie PY, Lu YM, Yu ZL. Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis. World J Gastroenterol 2005; 11(16): 2462-2466
- URL: https://www.wjgnet.com/1007-9327/full/v11/i16/2462.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i16.2462